Clinical Trial Update: Prophylaxis Roles of IL-2 Treatment on GVHD After Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial update exploring prophylactic IL-2 treatment to prevent or mitigate acute graft-versus-host disease after transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• IL-2 (Interleukin-2)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Acute Graft-versus-host Disease | Phase 2 | Status: UNKNOWN